Inclusion complexes and self-assembled cyclodextrin aggregates for increasing the solubility of benzimidazoles
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/164794 |
Resumo: | Albendazole and fenbendazole are imidazole derivatives that exhibit broad spectrum activity against parasites, but the low solubility of these drugs considerably reduces their effectiveness. Complexation of albendazole and fenbendazole with cyclodextrins (β-cyclodextrin and hydroxypropyl-β-cyclodextrin) in both water and an aqueous solution of polyvinylpyrrolidone (PVP-k30) was studied to determine if it could increase the solubility and dissolution rate of the drugs. In an aqueous solution, β-cyclodextrin increased the solubility of albendazole from 0.4188 to ∼93.47 µg mL-1 (223×), and of fenbendazole from 0.1054 to 45.56 µg mL-1 (432×); hydroxypropyl-β-cyclodextrin, on the other hand, increased solubility to ∼443.06 µg mL-1 (1058×) for albendazole and ∼159.36 μg mL-1 (1512×) for fenbendazole. The combination of hydroxypropyl-β-cyclodextrin and polyvinylpyrrolidone enabled a solubility increase of 1412× (∼591.22 µg mL-1 ) for albendazole and 1373× (∼144.66 µg mL-1 ) for fenbendazole. The dissolution rate of the drugs was significantly increased in binary and ternary systems, with hydroxypropyl-β-cyclodextrin proving to be more effective. The presence of the water-soluble PVP-k30 increased the dissolution rate and amorphization of the complexes. Analysis of the changes in displacement and the profile of the cyclodextrin bands in the 1 H NMR spectra revealed a molecular interaction and pointed to an effective complexation in the drug/cyclodextrin systems. Monomeric forms and nanoclusters of cyclodextrins were observed in the drug/cyclodextrin systems, suggesting that the increase in solubility of the drugs in the presence of cyclodextrins should not be attributed only to the formation of inclusion complexes, but also to the formation of cyclodextrin aggregates. |
id |
USP-31_6972ad732df8999217166e955212a621 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/164794 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
repository_id_str |
|
spelling |
Inclusion complexes and self-assembled cyclodextrin aggregates for increasing the solubility of benzimidazolesCyclodextrins/pharmacokineticsBenzimidazoles/administration & dosageInclusion complexesCyclodextrin aggregatesDrug liberation/drug effectsAntiparasitic agents/analysisAlbendazole/analysisFenbendazole/analysisAlbendazole and fenbendazole are imidazole derivatives that exhibit broad spectrum activity against parasites, but the low solubility of these drugs considerably reduces their effectiveness. Complexation of albendazole and fenbendazole with cyclodextrins (β-cyclodextrin and hydroxypropyl-β-cyclodextrin) in both water and an aqueous solution of polyvinylpyrrolidone (PVP-k30) was studied to determine if it could increase the solubility and dissolution rate of the drugs. In an aqueous solution, β-cyclodextrin increased the solubility of albendazole from 0.4188 to ∼93.47 µg mL-1 (223×), and of fenbendazole from 0.1054 to 45.56 µg mL-1 (432×); hydroxypropyl-β-cyclodextrin, on the other hand, increased solubility to ∼443.06 µg mL-1 (1058×) for albendazole and ∼159.36 μg mL-1 (1512×) for fenbendazole. The combination of hydroxypropyl-β-cyclodextrin and polyvinylpyrrolidone enabled a solubility increase of 1412× (∼591.22 µg mL-1 ) for albendazole and 1373× (∼144.66 µg mL-1 ) for fenbendazole. The dissolution rate of the drugs was significantly increased in binary and ternary systems, with hydroxypropyl-β-cyclodextrin proving to be more effective. The presence of the water-soluble PVP-k30 increased the dissolution rate and amorphization of the complexes. Analysis of the changes in displacement and the profile of the cyclodextrin bands in the 1 H NMR spectra revealed a molecular interaction and pointed to an effective complexation in the drug/cyclodextrin systems. Monomeric forms and nanoclusters of cyclodextrins were observed in the drug/cyclodextrin systems, suggesting that the increase in solubility of the drugs in the presence of cyclodextrins should not be attributed only to the formation of inclusion complexes, but also to the formation of cyclodextrin aggregates.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2019-12-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/16479410.1590/s2175-97902019000117776Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e17776Brazilian Journal of Pharmaceutical Sciences; v. 55 (2019); e17776Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e177762175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/164794/157978Copyright (c) 2019 Brazilian Journal of Pharmaceutical Scienceshttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessRodrigues, Leticia Norma CarpentieriTavares, Anna Carollina MoraesFerreira, Beatriz TavaresReis, Adriana Karla Cardoso AmorimKatiki, Luciana Morita2021-01-11T18:41:22Zoai:revistas.usp.br:article/164794Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2021-01-11T18:41:22Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Inclusion complexes and self-assembled cyclodextrin aggregates for increasing the solubility of benzimidazoles |
title |
Inclusion complexes and self-assembled cyclodextrin aggregates for increasing the solubility of benzimidazoles |
spellingShingle |
Inclusion complexes and self-assembled cyclodextrin aggregates for increasing the solubility of benzimidazoles Rodrigues, Leticia Norma Carpentieri Cyclodextrins/pharmacokinetics Benzimidazoles/administration & dosage Inclusion complexes Cyclodextrin aggregates Drug liberation/drug effects Antiparasitic agents/analysis Albendazole/analysis Fenbendazole/analysis |
title_short |
Inclusion complexes and self-assembled cyclodextrin aggregates for increasing the solubility of benzimidazoles |
title_full |
Inclusion complexes and self-assembled cyclodextrin aggregates for increasing the solubility of benzimidazoles |
title_fullStr |
Inclusion complexes and self-assembled cyclodextrin aggregates for increasing the solubility of benzimidazoles |
title_full_unstemmed |
Inclusion complexes and self-assembled cyclodextrin aggregates for increasing the solubility of benzimidazoles |
title_sort |
Inclusion complexes and self-assembled cyclodextrin aggregates for increasing the solubility of benzimidazoles |
author |
Rodrigues, Leticia Norma Carpentieri |
author_facet |
Rodrigues, Leticia Norma Carpentieri Tavares, Anna Carollina Moraes Ferreira, Beatriz Tavares Reis, Adriana Karla Cardoso Amorim Katiki, Luciana Morita |
author_role |
author |
author2 |
Tavares, Anna Carollina Moraes Ferreira, Beatriz Tavares Reis, Adriana Karla Cardoso Amorim Katiki, Luciana Morita |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Rodrigues, Leticia Norma Carpentieri Tavares, Anna Carollina Moraes Ferreira, Beatriz Tavares Reis, Adriana Karla Cardoso Amorim Katiki, Luciana Morita |
dc.subject.por.fl_str_mv |
Cyclodextrins/pharmacokinetics Benzimidazoles/administration & dosage Inclusion complexes Cyclodextrin aggregates Drug liberation/drug effects Antiparasitic agents/analysis Albendazole/analysis Fenbendazole/analysis |
topic |
Cyclodextrins/pharmacokinetics Benzimidazoles/administration & dosage Inclusion complexes Cyclodextrin aggregates Drug liberation/drug effects Antiparasitic agents/analysis Albendazole/analysis Fenbendazole/analysis |
description |
Albendazole and fenbendazole are imidazole derivatives that exhibit broad spectrum activity against parasites, but the low solubility of these drugs considerably reduces their effectiveness. Complexation of albendazole and fenbendazole with cyclodextrins (β-cyclodextrin and hydroxypropyl-β-cyclodextrin) in both water and an aqueous solution of polyvinylpyrrolidone (PVP-k30) was studied to determine if it could increase the solubility and dissolution rate of the drugs. In an aqueous solution, β-cyclodextrin increased the solubility of albendazole from 0.4188 to ∼93.47 µg mL-1 (223×), and of fenbendazole from 0.1054 to 45.56 µg mL-1 (432×); hydroxypropyl-β-cyclodextrin, on the other hand, increased solubility to ∼443.06 µg mL-1 (1058×) for albendazole and ∼159.36 μg mL-1 (1512×) for fenbendazole. The combination of hydroxypropyl-β-cyclodextrin and polyvinylpyrrolidone enabled a solubility increase of 1412× (∼591.22 µg mL-1 ) for albendazole and 1373× (∼144.66 µg mL-1 ) for fenbendazole. The dissolution rate of the drugs was significantly increased in binary and ternary systems, with hydroxypropyl-β-cyclodextrin proving to be more effective. The presence of the water-soluble PVP-k30 increased the dissolution rate and amorphization of the complexes. Analysis of the changes in displacement and the profile of the cyclodextrin bands in the 1 H NMR spectra revealed a molecular interaction and pointed to an effective complexation in the drug/cyclodextrin systems. Monomeric forms and nanoclusters of cyclodextrins were observed in the drug/cyclodextrin systems, suggesting that the increase in solubility of the drugs in the presence of cyclodextrins should not be attributed only to the formation of inclusion complexes, but also to the formation of cyclodextrin aggregates. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-12-05 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/164794 10.1590/s2175-97902019000117776 |
url |
https://www.revistas.usp.br/bjps/article/view/164794 |
identifier_str_mv |
10.1590/s2175-97902019000117776 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/164794/157978 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2019 Brazilian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2019 Brazilian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e17776 Brazilian Journal of Pharmaceutical Sciences; v. 55 (2019); e17776 Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e17776 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1800222914498265088 |